Malaria Clinical Trial
Official title:
Strengthening Referral of Sick Children Form the Private Health Sector
Uganda's under-five mortality is high, currently estimated at 90/1000 live births (Uganda
Bureau of Statistics 2011). Poor referral of sick children that seek care from the private
sector is one of the contributory factors. The proposed intervention aims to improve uptake
of referral advice for children that seek care from private facilities (registered drug
shops/private clinics).
The project will be implemented in Mukono district, central Uganda selected because a recent
concluded trial in the district showed that drug shop vendors (DSVs) adhere to diagnostic
test results, treat appropriately and refer sick children; although uptake of referral is
poor. The main reasons attributed to the observed poor referral were negative attitude
towards referral forms from drugs shops by the health workers at referral
facilities,perceptions of poor quality of care at referral facilities and costs involved
(Hutchinson. 2012; Hutchinson et al. 2013 in press)..
Thus the proposed project is a follow up to address these factors with the aim to improve
uptake of referral. This project is in line with the Uganda's Health sector and USAID
Mission's health priorities of strengthening the health system. Critical barriers in the
implementation of child survival interventions are poor quality of care in the private
sector and timely referral and uptake of referral advice at community level. These barriers
may be attributed to inadequate training of providers in the private sector (in diagnosis
and management of childhood illnesses); inadequate supervision and regulation; poor linkages
and collaboration between the public and private sectors; and non-existent linkages between
community structures and the private sector. The barriers will be addressed through an
intervention with three components; i) VHTs will be trained to do community sensitization
and initiate community discussions aimed at identifying community support mechanisms for
financial hardship (to be community led and managed) - e.g. communities to be encouraged to
establish community credit/insurance schemes for referral VHTs will register children and
facilitate follow up of sick children ii) supervision of providers in the private sector to
diagnose, treat and refer sick children, iii) regular meetings between the public and
private providers (convened by the district health team) to discuss the referral system.
| Status | Not yet recruiting |
| Enrollment | 8910 |
| Est. completion date | May 2017 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A to 5 Years |
| Eligibility |
Inclusion Criteria: - A cluster is defined to be a parish or neighboring parishes if the distance between any two private outlets located in each of the parishes is<1 km( to minimize possible spill over). - Any of the 63 parishes/clusters in Mukono district will be eligible if: i) Contain more than 200 households to ensure a sufficient number of sick children visiting the private outlets ii) Contained at least one registered drug shop/private clinic with the district drug inspector (DDI). iii) Contain a health centre II, the lowest public health facility where early treatment is sought. Exclusion Criteria: i) Unregistered drug shop/private clinic ii) No HFII government health facility located within the same parish iii) Fewer than 200 households in the parish where drug shop/private clinic is located iv) If the health facility does not have a qualified health worker. Some government health HCIIs in Uganda are run by nursing aides. |
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Ministry of Health, Uganda | Columbia University, LSHTM, Makerere University, College of Health Sciences Scholl of Public Health, University of Copenhagen |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The proportion of sick children referred from the private sector that complete the referral process (seen at higher level facilities). | This will be measured as a proportion of referred sick children of the total number of sick children | 2 years | No |
| Secondary | The proportion of sick children seeking care and receiving prompt treatment at private outlets within 24 hours of onset of symptoms; | Measured as the number of children seen at private facilities within 24 hours of the total number of sick children | 2 years | No |
| Secondary | The time between consultations at private outlets and uptake of referral at health facilities (referral facilities); | measure by time in hours | 2 years | No |
| Secondary | The cost-effectiveness of the intervention | The costs and effectiveness of the intervention per arm will be calculated as incremental cost per Disability Adjusted Life Years (DALY) averted of introducing a strengthened referral system (the cost-effectiveness) | 2years | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Completed |
NCT02536222 -
Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts
|
Phase 4 |